Cargando…
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
DNA methylation is tightly regulated throughout mammalian development, and altered DNA methylation patterns are a general hallmark of cancer. The methylcytosine dioxygenase TET2 is frequently mutated in hematological disorders, including acute myeloid leukemia (AML), and has been suggested to protec...
Autores principales: | Rasmussen, Kasper D., Jia, Guangshuai, Johansen, Jens V., Pedersen, Marianne T., Rapin, Nicolas, Bagger, Frederik O., Porse, Bo T., Bernard, Olivier A., Christensen, Jesper, Helin, Kristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421980/ https://www.ncbi.nlm.nih.gov/pubmed/25886910 http://dx.doi.org/10.1101/gad.260174.115 |
Ejemplares similares
-
TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells
por: Rasmussen, Kasper D., et al.
Publicado: (2019) -
Role of TET enzymes in DNA methylation, development, and cancer
por: Rasmussen, Kasper Dindler, et al.
Publicado: (2016) -
TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis
por: Tulstrup, Morten, et al.
Publicado: (2021) -
TET2 deficiency promotes MDS-associated leukemogenesis
por: Huang, Feiteng, et al.
Publicado: (2022) -
Correction: TET2 deficiency promotes MDS-associated leukemogenesis
por: Huang, Feiteng, et al.
Publicado: (2023)